Evidera — Morrisville, North Carolina

Evidera is a clinical research site located in Morrisville, North Carolina, United States 27560-7200.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Evidera has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment, Pregnancy Related, Narcolepsy.

Sponsors: AbbVie, Harmony Biosciences Management, Inc., Biogen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Morrisville

Browse all research sites in North Carolina · View every site in Morrisville

• University of North Carolina Chapel Hill
• Duke University
• University of North Carolina at Chapel Hill
• Duke University Medical Center, Department of Orthopaedic Surgery
• Science 37
• Research Site
• AAIPharma Inc., AAI Clinic
• Duke Health
• Duke Health Center Arringdon
• Science 37 - Virtual Site
• Syneos Health

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Evidera?

Evidera has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Evidera conducted?

Evidera has 3 clinical trials on record, with 3 currently active. Their work covers Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment, Pregnancy Related, Narcolepsy.

Is Evidera accredited by Crixeo Clinical Trials?

Evidera has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Evidera?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.